Cingulate
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cingulate and other ETFs, options, and stocks.About CING
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
CEOShane J. Schaffer
CEOShane J. Schaffer
Employees13
Employees13
HeadquartersKansas City, Kansas
HeadquartersKansas City, Kansas
Founded2012
Founded2012
Employees13
Employees13
CING Key Statistics
Market cap26.79M
Market cap26.79M
Price-Earnings ratio-0.73
Price-Earnings ratio-0.73
Dividend yield—
Dividend yield—
Average volume144.91K
Average volume144.91K
High today$4.07
High today$4.07
Low today$3.81
Low today$3.81
Open price$3.90
Open price$3.90
Volume128.48K
Volume128.48K
52 Week high$6.01
52 Week high$6.01
52 Week low$3.20
52 Week low$3.20
Stock Snapshot
Cingulate(CING) stock is priced at $3.85, giving the company a market capitalization of 26.79M. It carries a P/E multiple of -0.73.
As of 2025-12-19, Cingulate(CING) stock has fluctuated between $3.81 and $4.07. The current price stands at $3.85, placing the stock +1.0% above today's low and -5.3% off the high.
Cingulate(CING) shares are trading with a volume of 128.48K, against a daily average of 144.91K.
In the last year, Cingulate(CING) shares hit a 52-week high of $6.01 and a 52-week low of $3.20.
In the last year, Cingulate(CING) shares hit a 52-week high of $6.01 and a 52-week low of $3.20.
People also own
Based on the portfolios of people who own CING. This list is generated using Robinhood data, and it’s not a recommendation.